342
Views
6
CrossRef citations to date
0
Altmetric
Ophthalmology: Original Article

Fixed-combination brimonidine–timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study

, , , , , & show all
Pages 781-788 | Accepted 27 Mar 2012, Published online: 25 Apr 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Elad Moisseiev, Shimon Kurtz, Moshe Lazar & Gabi Shemesh. (2013) Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily. Clinical Ophthalmology 7, pages 1269-1273.
Read now

Articles from other publishers (5)

Bjorn Kaijun Betzler, Stephanie M. Young & Gangadhara Sundar. (2021) Intraocular Pressure and Glaucoma in Thyroid Eye Disease. Ophthalmic Plastic & Reconstructive Surgery 38:3, pages 219-225.
Crossref
Tao Wang, Linlin Cao, Qikun Jiang & Tianhong Zhang. (2021) Topical Medication Therapy for Glaucoma and Ocular Hypertension. Frontiers in Pharmacology 12.
Crossref
Magdalena Gumińska, Roman Goś, Janusz Śmigielski & Michał S. Nowak. (2020) Topical Treatment of Elevated Intraocular Pressure in Patients with Graves’ Orbitopathy. International Journal of Environmental Research and Public Health 17:24, pages 9331.
Crossref
Ujwala S. Saboo, Francisco Amparo, Hasanain Shikari & Reza Dana. (2016) Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease. Graefe's Archive for Clinical and Experimental Ophthalmology 254:5, pages 923-928.
Crossref
Italo Giuffre. (2012) Comparative Evaluation of the Efficacy of the Bimatoprost 0.03%, Brimonidine 0.2%, Brinzolamide 1%, Dorzolamide 2%, and Travoprost 0.004%/Timolol 0.5%-Fixed Combinations in Patients Affected by Open-Angle Glaucoma. Open Journal of Ophthalmology 02:04, pages 122-126.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.